Allergan Announces Intent to File New Drug Application for Bimatoprost as Novel Treatment to Stimulate Natural Eyelash Growth
June 4, 2008
Allergan, Inc. announced today that it intends to file a New Drug Application for bimatoprost, a synthetic prostaglandin analog, as a treatment to stimulate eyelash growth. Allergan has completed its clinical trial program demonstrating that its patented formulation of bimatoprost, when applied directly to the base of the eyelashes, results in significant eyelash growth. Read more
Research Shows VASER Ultrasound Assisted Lipoplasty Patients Experience Significantly Lower Blood Loss
June 4, 2008
Results of study presented at American Society for Aesthetic Plastic Surgery annual meeting demonstrate only minor bruising; findings indicate VASER® ultrasound-assisted device should be considered for large volume lipoplasty procedures Read more
FDA approves first HA-lidocaine filler for U.S. market
June 1, 2008
The recent FDA approval of Prevelle Silk (Mentor, Santa Barbara, Calif.) represents the first in what will likely be a wave of hyaluronic acid (HA) dermal fillers containing lidocaine coming to the U.S. market.
The product was approved in March after a controlled clinical study indicated that patients experienced significantly less pain during injection with the product compared to an HA product without lidocaine. It is indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds). Read more
IAPAM Aesthetic Medicine Resources
